cardiovascular benefits of glp 1 agonists The GLP-1 Therapy: Beyond Weight Loss The cardiovascular effects of GLP-1

This is referred to as an obesogenic diet (Ikemoto et al., 1996)

Weekly injections remain foundational, but daily oral therapy adds another entry point into care, particularly for patients hesitant about needles or seeking a treatment that fits more seamlessly into a morning routine

1.4.4 The scope and strategy of this review Current metabolic-centric approaches fail to address the reproductive complexities of PCOS

As a dual GIP/GLP-1 receptor agonist, it targets two hormonal pathways instead of one

Higher concentration solutions provide a stronger diffusion gradient

The 2025 review also reported that in a large retrospective study of 461,328 adults initiating GLP-1 therapy, over 22% developed at least one nutritional deficiency within 12 months, with vitamin D the most common deficiency identified